Wednesday, June 17, 2026

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions

German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions

Techniker Krankenkasse, Germany’s largest health insurance company, reported that 437,593 of 11 million (1 in 25) insured individuals in 2021 had to undergo medical treatment as a result of adverse reactions from COVID-19 shots.1 COVID shots currently approved for use in Germany include Novavax’s Nuvaxovid, Moderna’s Spikevax, Pfizer/BioNTech’s Comirnaty, Johnson & Johnson/Janssen’s Ad26.COV2.S, AstraZeneca/Oxford University’s […]

Herpes Zoster Reactivated Following mRNA COVID Shots, Studies Show

Herpes Zoster Reactivated Following mRNA COVID Shots, Studies Show

Concerns about the adverse effects of mRNA COVID-19 shots continue to grow a year and a half after they began to be distributed under an Emergency Use Authorization (EUA) granted to Pfizer/BioNTech and Moderna by the U.S. Food and Drug Administration (FDA). Cases of herpes zoster (HZ) following messenger RNA (mRNA) COVID shots have been […]

Japanese Government Pays Family for Death Tied to COVID Shot

Japanese Government Pays Family for Death Tied to COVID Shot

On July 25, 2022, a committee of Japan’s Ministry of Health, Labor and Welfare announced that it would provide a lump-sum death benefit of ¥44.2 million ($324,000), plus an additional ¥212,000 for funeral expenses, to the family of an elderly woman who died shortly after receiving a COVID-19 shot. The committee determined there was a […]

FDA Grants EUA for Novavax’s COVID Vaccine

FDA Grants EUA for Novavax’s COVID Vaccine

Opinion | On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax to distribute its experimental two-dose NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine for use by adults. The decision was expected, given the favorable recommendation by the FDA’s Vaccines and Related Biological Products Advisory […]

‘COVID-19 Rebound’ May Be Worse Than Initial COVID Illness

‘COVID-19 Rebound’ May Be Worse Than Initial COVID Illness

On May 24, 2022, the U.S. Centers for Disease Control and Prevention (CDC) issued a health advisory to health care providers, public health departments and the general public regarding Pfizer’s antiviral drug Paxlovid, designed to treat symptoms of COVID-19. The advisory warns that some people who take Paxlovid may experience a recurrence of COVID symptoms […]

Search in Site

To search in site, type your keyword and hit enter

Search